Harun AKAR, Utku Erdem SOYALTIN, Ayfer COLAK, Andac KOMAC, Hayrullah DURAK

Evaluation of ischemia-modified albumin levels and parametersof arterial stiffness in patients with hypothyroidism

Aim: The cardiovascular system is susceptible to thyroid hormones. Many studies show that hypothyroidism is associated with increased cardiovascular risk, functional abnormalities, atherosclerosis, and increased arterial stiffness. Pulse wave velocity (PWV) and augmentation index (AI) are regarded as indexes of arterial stiffness. Oxidative free radicals that occur during ischemic events cause certain chemical changes in the albumin molecules. The ischemia-modified albumin (IMA) has been suggested as an indicator of oxidative stress. Evaluation of oxidative stress markers and parameters of arterial stiffness can shed light on the mechanism of increased cardiovascular risk in patients with hypothyroidism.Material and Methods: For this study, PWV, AI measurements, and IMA levels of 20 untreated patients with overt hypothyroidism (OH), 21 untreated patients with subclinical hypothyroidism (SH), and 30 healthy controls (control-CNT) were evaluated. Patients and the healthy controls’ gender, age, weight, height, body mass index, waist circumference, smoking habit and blood biochemical results were recorded.Results: PWV was found to be increased in patients with overt hypothyroidism; however, there was no difference in between subclinical hypothyroidism and control group(p=0,881). Also, PWV had a significant positive correlation with; age, BMI, waist circumference, blood glucose, uric acid, pulse pressure and systolic and diastolic blood pressures. IMA levels were not different in between the groups.Conclusion: Hence the increased CV risk in patients with hypothyroidism is a multifactorial state; the interplay of many factors determines it. Future studies with larger sample sizes are needed to evaluate the possible relationship among IMA levels, arterial stiffness parameters and cardiovascular risk factors in patients with hypothyroidism.

PDF

___

1. Biondi B, Klein I. Hypothyroidism as a risk factor for cardiovascular disease Endocrine 2004;24:1-13.
2. Hamilton PK, Lockhart CJ, Quinn CE, et al. Arterial stiffness: Clinical relevance, measurement and treatment. Clin Sci Lond 2007;113:157-70.
3. Lippi G, Montagnana M, Guidi GC. Albümin cobalt binding and ischemia modified albümin generation: an endogenous response to ischemia? Int J Cardiol 2006;108:410-1.
4. Reddy SV, Suchitra MM, Pradeep V, et al. Ischemia-modified albumin levels in overt and subclinical hypothyroidism J Endocrinol Invest 2015;38:885-90.
5. Ma SG, Yang LX, Bai F, et al. Ischemia-modifi ed albumin in patients with hyperthyroidism and hypothyroidism. Eur Intern Med 2012;23:136-40.
6. Dahiya K, Verma M, Dhankari R, et al. Alteration of ischemia-modified albumin and nitric oxide levels in hypothyroidism. Clin Lab 2014;60:969-72.
7. Duntas LH. Thyroid disease and lipids. Thyroid 2002;12:267-93.
8. Kek PC, Ho SC, Khoo DH, Subclinical tyroid disease. Singapore Med J 2003;44;595-600.
9. Hamano K, Inoue M. Increased risk for atherosclerosis estimated by pulse wave velocity in hypothyroidism and its reversal with appropriate thyroxine treatment. Endocr J 2005;52:95-101.
10. Hansen TW, Staessen JA, Torp-Pedersen C, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population Circulation 2006;113:664-70.
11. Belen E, Değirmencioğlu A, Zencirci E, et al. The association between subclinical hypothyroidism and epicardial adipose tissue thickness Korean Circ J 2015;45:210-5.
12. Dagre AG, Lekakis JP, Papaioannou TG, et al. Arterial stiffness is increased in subjects with hypothyroidism. Int J Cardiol 2005;103:1-6.
13. Nagasaki T, Inaba M, Yamada S, et al Decrease of brachial-ankle pulse wave velocity in female subclinical hypothyroid patients during normalization of thyroid function: a double-blind, placebo-controlled study. Eur J Endocrinol 2009;160:409-15.
14. Biondi B, Klein I. Hypothyroidism as a risk factor for cardiovascular disease Endocrine 2004;24:1-13.
15. Lippi G, Montagnana M, Guidi GC. Albümin cobalt binding and ischemia modified albümin generation: an endogenous response to ischemia? Int J Cardiol 2006;108 410-1.
16. Ma SG, Yang LX, Bai F, et al. Ischemia-modifi ed albumin in patients with hyperthyroidism and hypothyroidism, Eur J Intern Med 2012;23:e136-40.
17. Ersoy K, Anaforoğlu İ, Algün E. Serum ischemic modified albumin levels might not be a marker of oxidative stress in patients with hypothyroidism. Endocrine 2013;43:430-3.
18. Nagano M, Nakamura M, Sato K, et al. Association between serum C-reactive protein levels and pulse wave velocity: a population-based cross-sectional study in a general population. Atherosclerosis 2005;180:189-95.